製剤開発アウトソーシング市場、規模、シェア、産業分析レポート：製剤別、サービス別、治療分野別、最終用途別、地域別、2025年～2034年の市場予測

Polaris Market Researchの最新調査によると、製剤開発アウトソーシング市場規模は2034年までに835億5,000万米ドルに達する見込みです。本レポートでは、現在の市場力学を詳細に洞察し、将来の市場成長に関する分析を提供しています。

製剤開発アウトソーシング市場には、前臨床および臨床段階の製剤活動を専門の研究開発・製造受託機関（CDMO）や研究開発業務受託機関（CRO）に外部委託することが含まれます。これらのサービスは、特に複雑で難溶性の化合物について、医薬品有効成分（API）の送達、安定性、バイオアベイラビリティを最適化する上で製薬・バイオ医薬品企業をサポートします。同市場は、医薬品パイプラインにおける分子の複雑化、特殊なデリバリーシステムに対する需要の高まり、コスト制約下で開発期間を短縮する必要性などを背景に、持続的な成長を遂げています。アウトソーシングは、ナノ製剤、徐放性プラットフォーム、溶解性向上技術など、社内で維持するにはコスト高になりがちな高度な機能を利用できるようにするために不可欠となっています。業界を形成する重要な動向は、製剤開発を創薬から商業化までの幅広いエンドツーエンドのサービスモデルに統合することです。さらに、予測モデリング、ハイスループットスクリーニング、データ駆動型製剤分析の導入は、製剤決定の方法を変革し、失敗率とサイクルタイムを削減しています。

少量生産で高度にカスタマイズされた製剤には、機敏で技術力のあるアウトソーシングパートナーが必要です。規制当局の監視が強化されるにつれ、プロバイダーは強固なQbDとリスクベースの手法の採用を迫られ、その戦略的価値はさらに高まっています。デジタル化、モジュール化されたサービス提供、リアルタイムのバッチモニタリングの重視の高まりは、顧客とプロバイダーの関係を再構築し、パフォーマンスとコンプライアンスのベンチマークを再定義すると予想されます。市場の進化は、科学的イノベーションと、複雑化する治療と規制状況における業務の柔軟性に対する戦略的ニーズが原動力となっています。

製剤開発アウトソーシング市場レポートハイライト

治療分野別では、2024年には、精密腫瘍治療薬に対する需要の急増と臨床パイプラインの急速な拡大ペースにより、腫瘍分野が最大のシェアを占める。

最終用途別では、トランスレーショナルリサーチや早期創薬における役割の拡大により、政府・学術機関分野が予測期間中に最も高いCAGRを記録すると予測されます。

2024年には、アジア太平洋地域がバイオ医薬品の技術革新の急増とジェネリック医薬品の急拡大により最大のシェアを占める。

北米の製剤開発アウトソーシング市場は、バイオベンチャー資本の急増に牽引され、予測期間中に最も高いCAGRを記録すると予測されます。

世界の主要市場プレーヤーとしては、キャタレント社、チャールズ・リバー・ラボラトリーズ・インターナショナル社、エレメント社、ユーロフィンズ・サイエンティフィック社、インターテック・グループ社、ラボコープ社、ロンザ社、レシファーム社、SGS S.A.、サーモフィッシャーサイエンティフィック社などが挙げられます。

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

第3章 調査手法

第4章 製剤開発アウトソーシング市場の洞察

• 市場スナップショット
• 製剤開発アウトソーシング市場力学
  • 促進要因と機会
    • バイオ医薬品およびジェネリック医薬品開発の成長
    • 製剤技術の進歩
  • 抑制要因と課題
    • 知的財産（IP）とデータセキュリティに関する懸念
• PESTEL分析
• 製剤開発アウトソーシング市場の力強さの評価動向
• バリューチェーン分析

第5章 製剤開発アウトソーシング市場：製剤別

• 主な調査結果
• イントロダクション
• 経口
• 注射
• 外用
• その他

第6章 製剤開発アウトソーシング市場：サービス別

• 主な調査結果
• イントロダクション
• 処方前
• 処方開発

第7章 製剤開発アウトソーシング市場：治療分野別

• 主な調査結果
• イントロダクション
• 腫瘍学
• 感染症
• 神経学
• 血液学
• 呼吸器
• 心血管系
• 皮膚科
• その他

第8章 製剤開発アウトソーシング市場：最終用途別

• 主な調査結果
• イントロダクション
• 製薬会社およびバイオ医薬品会社
• 政府機関および学術機関
• その他

第9章 製剤開発アウトソーシング市場：地域別

• 主な調査結果
• イントロダクション
  • 製剤開発アウトソーシング市場評価：地域別、2020～2034年
• 北米
  • 北米：配合別、2020～2034年
  • 北米：サービス別、2020～2034年
  • 北米：最終用途別、2020～2034年
  • 北米：治療分野別、2020～2034年
  • 米国
  • カナダ
• 欧州
  • 欧州：処方別、2020～2034年
  • 欧州：サービス別、2020～2034年
  • 欧州：最終用途別、2020～2034年
  • 欧州：治療分野別、2020～2034年
  • 英国
  • フランス
  • ドイツ
  • イタリア
  • スペイン
  • オランダ
  • ロシア
  • その他欧州
• アジア太平洋
  • アジア太平洋地域：製剤別、2020～2034年
  • アジア太平洋地域：サービス別、2020～2034年
  • アジア太平洋地域：最終用途別、2020～2034年
  • アジア太平洋地域：治療分野別、2020年～2034年
  • 中国
  • インド
  • マレーシア
  • 日本
  • インドネシア
  • 韓国
  • オーストラリア
  • その他アジア太平洋地域
• 中東・アフリカ
  • 中東・アフリカ：製剤別、2020～2034年
  • 中東・アフリカ：サービス別、2020～2034年
  • 中東・アフリカ：最終用途別、2020～2034年
  • 中東・アフリカ：治療分野別、2020～2034年
  • サウジアラビア
  • アラブ首長国連邦
  • イスラエル
  • 南アフリカ
  • その他中東とアフリカ
• ラテンアメリカ
  • ラテンアメリカ：製剤別、2020～2034年
  • ラテンアメリカ：サービス別、2020～2034年
  • ラテンアメリカ：最終用途別、2020～2034年
  • ラテンアメリカ：治療分野別、2020-2034年
  • メキシコ
  • ブラジル
  • アルゼンチン
  • その他ラテンアメリカ

第10章 競合情勢

• 拡大と買収の分析
  • 拡大
  • 買収
• 提携/協業/合意/公開

第11章 企業プロファイル

• Catalent Inc.
• Charles River Laboratories International, Inc.
• Element
• Eurofins Scientific SE
• Intertek Group plc
• Labcorp
• Lonza
• Recipharm
• SGS S.A.
• Thermo Fisher Scientific, Inc.

List of Tables:

• Table 1 Formulation Development Outsourcing Market, By Formulation, 2020-2034 (USD Billion)
• Table 2 Formulation Development Outsourcing Market, By Service, 2020-2034 (USD Billion)
• Table 3 Formulation Development Outsourcing Market, by End Use, 2020-2034 (USD Billion)
• Table 4 Formulation Development Outsourcing Market, by Therapeutic Area, 2020-2034 (USD Billion)
• Table 5 North America: Formulation Development Outsourcing Market, By Formulation, 2020-2034 (USD Billion)
• Table 6 North America: Formulation Development Outsourcing Market, By Service, 2020-2034 (USD Billion)
• Table 7 North America: Formulation Development Outsourcing Market, by End Use, 2020-2034 (USD Billion)
• Table 8 North America: Formulation Development Outsourcing Market, by Therapeutic Area, 2020-2034 (USD Billion)
• Table 9 US: Formulation Development Outsourcing Market, By Formulation, 2020-2034 (USD Billion)
• Table 10 US: Formulation Development Outsourcing Market, By Service, 2020-2034 (USD Billion)
• Table 11 US: Formulation Development Outsourcing Market, by End Use, 2020-2034 (USD Billion)
• Table 12 US: Formulation Development Outsourcing Market, by Therapeutic Area, 2020-2034 (USD Billion)
• Table 13 Canada: Formulation Development Outsourcing Market, By Formulation, 2020-2034 (USD Billion)
• Table 14 Canada: Formulation Development Outsourcing Market, By Service, 2020-2034 (USD Billion)
• Table 15 Canada: Formulation Development Outsourcing Market, by End Use, 2020-2034 (USD Billion)
• Table 16 Canada: Formulation Development Outsourcing Market, by Therapeutic Area, 2020-2034 (USD Billion)
• Table 17 Europe: Formulation Development Outsourcing Market, By Formulation, 2020-2034 (USD Billion)
• Table 18 Europe: Formulation Development Outsourcing Market, By Service, 2020-2034 (USD Billion)
• Table 19 Europe: Formulation Development Outsourcing Market, by End Use, 2020-2034 (USD Billion)
• Table 20 Europe: Formulation Development Outsourcing Market, by Therapeutic Area, 2020-2034 (USD Billion)
• Table 21 UK: Formulation Development Outsourcing Market, By Formulation, 2020-2034 (USD Billion)
• Table 22 UK: Formulation Development Outsourcing Market, By Service, 2020-2034 (USD Billion)
• Table 23 UK: Formulation Development Outsourcing Market, by End Use, 2020-2034 (USD Billion)
• Table 24 UK: Formulation Development Outsourcing Market, by Therapeutic Area, 2020-2034 (USD Billion)
• Table 25 France: Formulation Development Outsourcing Market, By Formulation, 2020-2034 (USD Billion)
• Table 26 France: Formulation Development Outsourcing Market, By Service, 2020-2034 (USD Billion)
• Table 27 France: Formulation Development Outsourcing Market, by End Use, 2020-2034 (USD Billion)
• Table 28 France: Formulation Development Outsourcing Market, by Therapeutic Area, 2020-2034 (USD Billion)
• Table 29 Germany: Formulation Development Outsourcing Market, By Formulation, 2020-2034 (USD Billion)
• Table 30 Germany: Formulation Development Outsourcing Market, By Service, 2020-2034 (USD Billion)
• Table 31 Germany: Formulation Development Outsourcing Market, by End Use, 2020-2034 (USD Billion)
• Table 32 Germany: Formulation Development Outsourcing Market, by Therapeutic Area, 2020-2034 (USD Billion)
• Table 33 Italy: Formulation Development Outsourcing Market, By Formulation, 2020-2034 (USD Billion)
• Table 34 Italy: Formulation Development Outsourcing Market, By Service, 2020-2034 (USD Billion)
• Table 35 Italy: Formulation Development Outsourcing Market, by End Use, 2020-2034 (USD Billion)
• Table 36 Italy: Formulation Development Outsourcing Market, by Therapeutic Area, 2020-2034 (USD Billion)
• Table 37 Spain: Formulation Development Outsourcing Market, By Formulation, 2020-2034 (USD Billion)
• Table 38 Spain: Formulation Development Outsourcing Market, By Service, 2020-2034 (USD Billion)
• Table 39 Spain: Formulation Development Outsourcing Market, by End Use, 2020-2034 (USD Billion)
• Table 40 Spain: Formulation Development Outsourcing Market, by Therapeutic Area, 2020-2034 (USD Billion)
• Table 41 Netherlands: Formulation Development Outsourcing Market, By Formulation, 2020-2034 (USD Billion)
• Table 42 Netherlands: Formulation Development Outsourcing Market, By Service, 2020-2034 (USD Billion)
• Table 43 Netherlands: Formulation Development Outsourcing Market, by End Use, 2020-2034 (USD Billion)
• Table 44 Netherlands: Formulation Development Outsourcing Market, by Therapeutic Area, 2020-2034 (USD Billion)
• Table 45 Russia: Formulation Development Outsourcing Market, By Formulation, 2020-2034 (USD Billion)
• Table 46 Russia: Formulation Development Outsourcing Market, By Service, 2020-2034 (USD Billion)
• Table 47 Russia: Formulation Development Outsourcing Market, by End Use, 2020-2034 (USD Billion)
• Table 48 Russia: Formulation Development Outsourcing Market, by Therapeutic Area, 2020-2034 (USD Billion)
• Table 49 Rest of Europe: Formulation Development Outsourcing Market, By Formulation, 2020-2034 (USD Billion)
• Table 50 Rest of Europe: Formulation Development Outsourcing Market, By Service, 2020-2034 (USD Billion)
• Table 51 Rest of Europe: Formulation Development Outsourcing Market, by End Use, 2020-2034 (USD Billion)
• Table 52 Rest of Europe: Formulation Development Outsourcing Market, by Therapeutic Area, 2020-2034 (USD Billion)
• Table 53 Asia Pacific: Formulation Development Outsourcing Market, By Formulation, 2020-2034 (USD Billion)
• Table 54 Asia Pacific: Formulation Development Outsourcing Market, By Service, 2020-2034 (USD Billion)
• Table 55 Asia Pacific: Formulation Development Outsourcing Market, by End Use, 2020-2034 (USD Billion)
• Table 56 Asia Pacific: Formulation Development Outsourcing Market, by Therapeutic Area, 2020-2034 (USD Billion)
• Table 57 China: Formulation Development Outsourcing Market, By Formulation, 2020-2034 (USD Billion)
• Table 58 China: Formulation Development Outsourcing Market, By Service, 2020-2034 (USD Billion)
• Table 59 China: Formulation Development Outsourcing Market, by End Use, 2020-2034 (USD Billion)
• Table 60 China: Formulation Development Outsourcing Market, by Therapeutic Area, 2020-2034 (USD Billion)
• Table 61 India: Formulation Development Outsourcing Market, By Formulation, 2020-2034 (USD Billion)
• Table 62 India: Formulation Development Outsourcing Market, By Service, 2020-2034 (USD Billion)
• Table 63 India: Formulation Development Outsourcing Market, by End Use, 2020-2034 (USD Billion)
• Table 64 India: Formulation Development Outsourcing Market, by Therapeutic Area, 2020-2034 (USD Billion)
• Table 65 Malaysia: Formulation Development Outsourcing Market, By Formulation, 2020-2034 (USD Billion)
• Table 66 Malaysia: Formulation Development Outsourcing Market, By Service, 2020-2034 (USD Billion)
• Table 67 Malaysia: Formulation Development Outsourcing Market, by End Use, 2020-2034 (USD Billion)
• Table 68 Malaysia: Formulation Development Outsourcing Market, by Therapeutic Area, 2020-2034 (USD Billion)
• Table 69 Japan: Formulation Development Outsourcing Market, By Formulation, 2020-2034 (USD Billion)
• Table 70 Japan: Formulation Development Outsourcing Market, By Service, 2020-2034 (USD Billion)
• Table 71 Japan: Formulation Development Outsourcing Market, by End Use, 2020-2034 (USD Billion)
• Table 72 Japan: Formulation Development Outsourcing Market, by Therapeutic Area, 2020-2034 (USD Billion)
• Table 73 Indonesia: Formulation Development Outsourcing Market, By Formulation, 2020-2034 (USD Billion)
• Table 74 Indonesia: Formulation Development Outsourcing Market, By Service, 2020-2034 (USD Billion)
• Table 75 Indonesia: Formulation Development Outsourcing Market, by End Use, 2020-2034 (USD Billion)
• Table 76 Indonesia: Formulation Development Outsourcing Market, by Therapeutic Area, 2020-2034 (USD Billion)
• Table 77 South Korea: Formulation Development Outsourcing Market, By Formulation, 2020-2034 (USD Billion)
• Table 78 South Korea: Formulation Development Outsourcing Market, By Service, 2020-2034 (USD Billion)
• Table 79 South Korea: Formulation Development Outsourcing Market, by End Use, 2020-2034 (USD Billion)
• Table 80 South Korea: Formulation Development Outsourcing Market, by Therapeutic Area, 2020-2034 (USD Billion)
• Table 81 Australia: Formulation Development Outsourcing Market, By Formulation, 2020-2034 (USD Billion)
• Table 82 Australia: Formulation Development Outsourcing Market, By Service, 2020-2034 (USD Billion)
• Table 83 Australia: Formulation Development Outsourcing Market, by End Use, 2020-2034 (USD Billion)
• Table 84 Australia: Formulation Development Outsourcing Market, by Therapeutic Area, 2020-2034 (USD Billion)
• Table 85 Rest of Asia Pacific: Formulation Development Outsourcing Market, By Formulation, 2020-2034 (USD Billion)
• Table 86 Rest of Asia Pacific: Formulation Development Outsourcing Market, By Service, 2020-2034 (USD Billion)
• Table 87 Rest of Asia Pacific: Formulation Development Outsourcing Market, by End Use, 2020-2034 (USD Billion)
• Table 88 Rest of Asia Pacific: Formulation Development Outsourcing Market, by Therapeutic Area, 2020-2034 (USD Billion)
• Table 89 Middle East & Africa: Formulation Development Outsourcing Market, By Formulation, 2020-2034 (USD Billion)
• Table 90 Middle East & Africa: Formulation Development Outsourcing Market, By Service, 2020-2034 (USD Billion)
• Table 91 Middle East & Africa: Formulation Development Outsourcing Market, by End Use, 2020-2034 (USD Billion)
• Table 92 Middle East & Africa: Formulation Development Outsourcing Market, by Therapeutic Area, 2020-2034 (USD Billion)
• Table 93 Saudi Arabia: Formulation Development Outsourcing Market, By Formulation, 2020-2034 (USD Billion)
• Table 94 Saudi Arabia: Formulation Development Outsourcing Market, By Service, 2020-2034 (USD Billion)
• Table 95 Saudi Arabia: Formulation Development Outsourcing Market, by End Use, 2020-2034 (USD Billion)
• Table 96 Saudi Arabia: Formulation Development Outsourcing Market, by Therapeutic Area, 2020-2034 (USD Billion)
• Table 97 UAE: Formulation Development Outsourcing Market, By Formulation, 2020-2034 (USD Billion)
• Table 98 UAE: Formulation Development Outsourcing Market, By Service, 2020-2034 (USD Billion)
• Table 99 UAE: Formulation Development Outsourcing Market, by End Use, 2020-2034 (USD Billion)
• Table 100 UAE: Formulation Development Outsourcing Market, by Therapeutic Area, 2020-2034 (USD Billion)
• Table 101 Israel: Formulation Development Outsourcing Market, By Formulation, 2020-2034 (USD Billion)
• Table 102 Israel: Formulation Development Outsourcing Market, By Service, 2020-2034 (USD Billion)
• Table 103 Israel: Formulation Development Outsourcing Market, by End Use, 2020-2034 (USD Billion)
• Table 104 Israel: Formulation Development Outsourcing Market, by Therapeutic Area, 2020-2034 (USD Billion)
• Table 105 South Africa: Formulation Development Outsourcing Market, By Formulation, 2020-2034 (USD Billion)
• Table 106 South Africa: Formulation Development Outsourcing Market, By Service, 2020-2034 (USD Billion)
• Table 107 South Africa: Formulation Development Outsourcing Market, by End Use, 2020-2034 (USD Billion)
• Table 108 South Africa: Formulation Development Outsourcing Market, by Therapeutic Area, 2020-2034 (USD Billion)
• Table 109 Rest of Middle East & Africa: Formulation Development Outsourcing Market, By Formulation, 2020-2034 (USD Billion)
• Table 110 Rest of Middle East & Africa: Formulation Development Outsourcing Market, By Service, 2020-2034 (USD Billion)
• Table 111 Rest of Middle East & Africa: Formulation Development Outsourcing Market, by End Use, 2020-2034 (USD Billion)
• Table 112 Rest of Middle East & Africa: Formulation Development Outsourcing Market, by Therapeutic Area, 2020-2034 (USD Billion)
• Table 113 Latin America: Formulation Development Outsourcing Market, By Formulation, 2020-2034 (USD Billion)
• Table 114 Latin America: Formulation Development Outsourcing Market, By Service, 2020-2034 (USD Billion)
• Table 115 Latin America: Formulation Development Outsourcing Market, by End Use, 2020-2034 (USD Billion)
• Table 116 Latin America: Formulation Development Outsourcing Market, by Therapeutic Area, 2020-2034 (USD Billion)
• Table 117 Mexico: Formulation Development Outsourcing Market, By Formulation, 2020-2034 (USD Billion)
• Table 118 Mexico: Formulation Development Outsourcing Market, By Service, 2020-2034 (USD Billion)
• Table 119 Mexico: Formulation Development Outsourcing Market, by End Use, 2020-2034 (USD Billion)
• Table 120 Mexico: Formulation Development Outsourcing Market, by Therapeutic Area, 2020-2034 (USD Billion)
• Table 121 Brazil: Formulation Development Outsourcing Market, By Formulation, 2020-2034 (USD Billion)
• Table 122 Brazil: Formulation Development Outsourcing Market, By Service, 2020-2034 (USD Billion)
• Table 123 Brazil: Formulation Development Outsourcing Market, by End Use, 2020-2034 (USD Billion)
• Table 124 Brazil: Formulation Development Outsourcing Market, by Therapeutic Area, 2020-2034 (USD Billion)
• Table 125 Argentina: Formulation Development Outsourcing Market, By Formulation, 2020-2034 (USD Billion)
• Table 126 Argentina: Formulation Development Outsourcing Market, By Service, 2020-2034 (USD Billion)
• Table 127 Argentina: Formulation Development Outsourcing Market, by End Use, 2020-2034 (USD Billion)
• Table 128 Argentina: Formulation Development Outsourcing Market, by Therapeutic Area, 2020-2034 (USD Billion)
• Table 129 Rest of Latin America: Formulation Development Outsourcing Market, By Formulation, 2020-2034 (USD Billion)
• Table 130 Rest of Latin America: Formulation Development Outsourcing Market, By Service, 2020-2034 (USD Billion)
• Table 131 Rest of Latin America: Formulation Development Outsourcing Market, by End Use, 2020-2034 (USD Billion)
• Table 132 Rest of Latin America: Formulation Development Outsourcing Market, by Therapeutic Area, 2020-2034 (USD Billion)

List of Figures:

• Figure 1. Formulation Development Outsourcing Market, 2020-2034 (USD Billion)
• Figure 2. Integrated Ecosystem
• Figure 3. Research Methodology: Top-Down & Bottom-Up Price
• Figure 4. Market by Geography
• Figure 5. Porter's Five Forces
• Figure 6. Market by Formulation
• Figure 7. Formulation Development Outsourcing Market, By Formulation, 2024 & 2034 (USD Billion)
• Figure 8. Market by Service
• Figure 9. Formulation Development Outsourcing Market, By Service, 2024 & 2034 (USD Billion)
• Figure 10. Market by End Use
• Figure 11. Formulation Development Outsourcing Market, by End Use, 2024 & 2034 (USD Billion)
• Figure 12. Market by Therapeutic Area
• Figure 13. Formulation Development Outsourcing Market, by Therapeutic Area, 2024 & 2034 (USD Billion)

The formulation development outsourcing market size is expected to reach USD 83.55 billion by 2034, according to a new study by Polaris Market Research. The report "Formulation Development Outsourcing Market Size, Share, & Industry Analysis Report: By Formulation, By Service (Preformulation and Formulation Development), By Therapeutic Area, By End Use, and By Region - Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The formulation development outsourcing market encompasses the externalization of preclinical and clinical-stage formulation activities to specialized contract development and manufacturing organizations (CDMOs) and contract research organizations (CROs). These services support pharmaceutical and biopharmaceutical companies in optimizing the delivery, stability, and bioavailability of active pharmaceutical ingredients (APIs), particularly for complex and poorly soluble compounds. The market is witnessing sustained growth driven by increasing molecular complexity in drug pipelines, rising demand for specialized delivery systems, and the need for accelerated development timelines under cost constraints. Outsourcing has become essential for enabling access to advanced capabilities such as nanoformulation, sustained-release platforms, and solubility enhancement technologies, which are often cost-prohibitive to maintain in-house. A significant trend shaping the industry is the integration of formulation development into broader end-to-end service models that span from discovery to commercialization. Additionally, the deployment of predictive modeling, high-throughput screening, and data-driven formulation analytics is transforming how formulation decisions are made, reducing failure rates and cycle times.

Industry growth opportunities are expanding in the area of personalized medicine, where small-batch, highly tailored formulations require agile and technologically equipped outsourcing partners. Increasing regulatory scrutiny is pushing providers to adopt robust QbD and risk-based methodologies, further enhancing their strategic value. The growing emphasis on digitalization, modular service delivery, and real-time batch monitoring is expected to reshape client-provider relationships and redefine benchmarks for performance and compliance. The market's evolution is being driven by scientific innovation and the strategic need for operational flexibility in an increasingly complex therapeutic and regulatory landscape.

Formulation Development Outsourcing Market Report Highlights

By therapeutic area, in 2024, the oncology segment held the largest share due to the surge in demand for precision oncology therapeutics and the rapid pace of clinical pipeline expansion.

Based on end use, the government and academic institutes segment is expected to witness the highest CAGR during the forecast period due to their expanding role in translational research and early-stage drug discovery.

In 2024, Asia Pacific held the largest share due to a surge in regional biopharmaceutical innovation and rapidly expanding generics industry.

The North America formulation development outsourcing market is projected to register the highest CAGR during the forecast period, driven by an upsurge in biotech venture capital.

A few global key market players include Catalent Inc.; Charles River Laboratories International, Inc.; Element; Eurofins Scientific SE; Intertek Group plc; Labcorp; Lonza; Recipharm; SGS S.A.; and Thermo Fisher Scientific, Inc.

Polaris Market Research has segmented the market report on the basis of formulation, service, therapeutic area, end use, and region:

By Formulation Outlook (Revenue, USD Billion, 2020-2034)

Oral

Injectable

Topical

Others

By Service Outlook (Revenue, USD Billion, 2020-2034)

Preformulation

Formulation Development

By Therapeutic Area Outlook (Revenue, USD Billion, 2020-2034)

Oncology

Infectious Disease

Neurology

Hematology

Respiratory

Cardiovascular

Dermatology

Others

By End Use Outlook (Revenue, USD Billion, 2020-2034)

Pharmaceutical and Biopharmaceutical Companies

Government and Academic Institutes

Others

By Regional Outlook (Revenue, USD Billion, 2020-2034)

North America

US

Canada

Europe

Germany

UK

France

Italy

Spain

Russia

Netherlands

Rest of Europe

Asia Pacific

China

India

Japan

South Korea

Indonesia

Malaysia

Vietnam

Australia

Rest of Asia Pacific

Latin America

Argentina

Brazil

Mexico

Rest of Latin America

Middle East & Africa

UAE

Saudi Arabia

Israel

South Africa

Rest of Middle East & Africa

Table of Contents

1. Introduction

• 1.1. Report Description
  • 1.1.1. Objectives of the Study
  • 1.1.2. Market Scope
  • 1.1.3. Assumptions
• 1.2. Stakeholders

2. Executive Summary

• 2.1. Market Highlights

3. Research Methodology

• 3.1. Overview
  • 3.1.1. Data Mining
• 3.2. Data Sources
  • 3.2.1. Primary Sources
  • 3.2.2. Secondary Sources

4. Formulation Development Outsourcing Market Insights

• 4.1. Formulation Development Outsourcing Market - Market Snapshot
• 4.2. Formulation Development Outsourcing Market Dynamics
  • 4.2.1. Drivers and Opportunities
    • 4.2.1.1. Growth in Biopharmaceutical and Generic Drug Development
    • 4.2.1.2. Advancements in Formulation Technologies
  • 4.2.2. Restraints and Challenges
    • 4.2.2.1. Intellectual Property (IP) and Data Security Concerns
• 4.3. Porter's Five Forces Analysis
  • 4.3.1. Bargaining Power of Suppliers (Moderate)
  • 4.3.2. Threats of New Entrants: (Low)
  • 4.3.3. Bargaining Power of Buyers (Moderate)
  • 4.3.4. Threat of Substitute (Moderate)
  • 4.3.5. Rivalry among existing firms (High)
• 4.4. PESTEL Analysis
• 4.5. Formulation Development Outsourcing Market Power Rating Trends
• 4.6. Value Chain Analysis

5. Formulation Development Outsourcing Market, by Formulation

• 5.1. Key Findings
• 5.2. Introduction
  • 5.2.1. Formulation Development Outsourcing Market, by Formulation, 2020-2034 (USD Billion)
• 5.3. Oral
  • 5.3.1. Formulation Development Outsourcing Market, by Oral, by Region, 2020-2034 (USD Billion)
• 5.4. Injectable
  • 5.4.1. Formulation Development Outsourcing Market, by Injectable, by Region, 2020-2034 (USD Billion)
• 5.5. Topical
  • 5.5.1. Formulation Development Outsourcing Market, by Topical, by Region, 2020-2034 (USD Billion)
• 5.6. Others
  • 5.6.1. Formulation Development Outsourcing Market, by Others, by Region, 2020-2034 (USD Billion)

6. Formulation Development Outsourcing Market, by Service

• 6.1. Key Findings
• 6.2. Introduction
  • 6.2.1. Formulation Development Outsourcing Market, By Service, 2020-2034 (USD Billion)
• 6.3. Preformulation
  • 6.3.1. Formulation Development Outsourcing Market, by Preformulation, by Region, 2020-2034 (USD Billion)
• 6.4. Formulation Development
  • 6.4.1. Formulation Development Outsourcing Market, by Formulation Development, by Region, 2020-2034 (USD Billion)

7. Formulation Development Outsourcing Market, by Therapeutic Area

• 7.1. Key Findings
• 7.2. Introduction
  • 7.2.1. Formulation Development Outsourcing Market, by Therapeutic Area, 2020-2034 (USD Billion)
• 7.3. Oncology
  • 7.3.1. Formulation Development Outsourcing Market, by Oncology, by Region, 2020-2034 (USD Billion)
• 7.4. Infectious Disease
  • 7.4.1. Formulation Development Outsourcing Market, by Infectious Disease, by Region, 2020-2034 (USD Billion)
• 7.5. Neurology
  • 7.5.1. Formulation Development Outsourcing Market, by Neurology, by Region, 2020-2034 (USD Billion)
• 7.6. Hematology
  • 7.6.1. Formulation Development Outsourcing Market, by Hematology, by Region, 2020-2034 (USD Billion)
• 7.7. Respiratory
  • 7.7.1. Formulation Development Outsourcing Market, by Respiratory, by Region, 2020-2034 (USD Billion)
• 7.8. Cardiovascular
  • 7.8.1. Formulation Development Outsourcing Market, by Cardiovascular, by Region, 2020-2034 (USD Billion)
• 7.9. Dermatology
  • 7.9.1. Formulation Development Outsourcing Market, by Dermatology, by Region, 2020-2034 (USD Billion)
• 7.10. Others
  • 7.10.1. Formulation Development Outsourcing Market, by Others, by Region, 2020-2034 (USD Billion)

8. Formulation Development Outsourcing Market, by End Use

• 8.1. Key Findings
• 8.2. Introduction
  • 8.2.1. Formulation Development Outsourcing Market, by End Use, 2020-2034 (USD Billion)
• 8.3. Pharmaceutical and Biopharmaceutical Companies
  • 8.3.1. Formulation Development Outsourcing Market, by Pharmaceutical and Biopharmaceutical Companies, by Region, 2020-2034 (USD Billion)
• 8.4. Government and Academic Institutes
  • 8.4.1. Formulation Development Outsourcing Market, by Government and Academic Institutes, by Region, 2020-2034 (USD Billion)
• 8.5. Others
  • 8.5.1. Formulation Development Outsourcing Market, by Others, by Region, 2020-2034 (USD Billion)

9. Formulation Development Outsourcing Market, by Geography

• 9.1. Key Findings
• 9.2. Introduction
  • 9.2.1. Formulation Development Outsourcing Market Assessment, By Geography, 2020-2034 (USD Billion)
• 9.3. Formulation Development Outsourcing Market - North America
  • 9.3.1. North America: Formulation Development Outsourcing Market, By Formulation, 2020-2034 (USD Billion)
  • 9.3.2. North America: Formulation Development Outsourcing Market, By Service, 2020-2034 (USD Billion)
  • 9.3.3. North America: Formulation Development Outsourcing Market, by End Use, 2020-2034 (USD Billion)
  • 9.3.4. North America: Formulation Development Outsourcing Market, by Therapeutic Area, 2020-2034 (USD Billion)
  • 9.3.5. Formulation Development Outsourcing Market - US
    • 9.3.5.1. US: Formulation Development Outsourcing Market, By Formulation, 2020-2034 (USD Billion)
    • 9.3.5.2. US: Formulation Development Outsourcing Market, By Service, 2020-2034 (USD Billion)
    • 9.3.5.3. US: Formulation Development Outsourcing Market, by End Use, 2020-2034 (USD Billion)
    • 9.3.5.4. US: Formulation Development Outsourcing Market, by Therapeutic Area, 2020-2034 (USD Billion)
  • 9.3.6. Formulation Development Outsourcing Market - Canada
    • 9.3.6.1. Canada: Formulation Development Outsourcing Market, By Formulation, 2020-2034 (USD Billion)
    • 9.3.6.2. Canada: Formulation Development Outsourcing Market, By Service, 2020-2034 (USD Billion)
    • 9.3.6.3. Canada: Formulation Development Outsourcing Market, by End Use, 2020-2034 (USD Billion)
    • 9.3.6.4. Canada: Formulation Development Outsourcing Market, by Therapeutic Area, 2020-2034 (USD Billion)
• 9.4. Formulation Development Outsourcing Market - Europe
  • 9.4.1. Europe: Formulation Development Outsourcing Market, By Formulation, 2020-2034 (USD Billion)
  • 9.4.2. Europe: Formulation Development Outsourcing Market, By Service, 2020-2034 (USD Billion)
  • 9.4.3. Europe: Formulation Development Outsourcing Market, by End Use, 2020-2034 (USD Billion)
  • 9.4.4. Europe: Formulation Development Outsourcing Market, by Therapeutic Area, 2020-2034 (USD Billion)
  • 9.4.5. Formulation Development Outsourcing Market - UK
    • 9.4.5.1. UK: Formulation Development Outsourcing Market, By Formulation, 2020-2034 (USD Billion)
    • 9.4.5.2. UK: Formulation Development Outsourcing Market, By Service, 2020-2034 (USD Billion)
    • 9.4.5.3. UK: Formulation Development Outsourcing Market, by End Use, 2020-2034 (USD Billion)
    • 9.4.5.4. UK: Formulation Development Outsourcing Market, by Therapeutic Area, 2020-2034 (USD Billion)
  • 9.4.6. Formulation Development Outsourcing Market - France
    • 9.4.6.1. France: Formulation Development Outsourcing Market, By Formulation, 2020-2034 (USD Billion)
    • 9.4.6.2. France: Formulation Development Outsourcing Market, By Service, 2020-2034 (USD Billion)
    • 9.4.6.3. France: Formulation Development Outsourcing Market, by End Use, 2020-2034 (USD Billion)
    • 9.4.6.4. France: Formulation Development Outsourcing Market, by Therapeutic Area, 2020-2034 (USD Billion)
  • 9.4.7. Formulation Development Outsourcing Market - Germany
    • 9.4.7.1. Germany: Formulation Development Outsourcing Market, By Formulation, 2020-2034 (USD Billion)
    • 9.4.7.2. Germany: Formulation Development Outsourcing Market, By Service, 2020-2034 (USD Billion)
    • 9.4.7.3. Germany: Formulation Development Outsourcing Market, by End Use, 2020-2034 (USD Billion)
    • 9.4.7.4. Germany: Formulation Development Outsourcing Market, by Therapeutic Area, 2020-2034 (USD Billion)
  • 9.4.8. Formulation Development Outsourcing Market - Italy
    • 9.4.8.1. Italy: Formulation Development Outsourcing Market, By Formulation, 2020-2034 (USD Billion)
    • 9.4.8.2. Italy: Formulation Development Outsourcing Market, By Service, 2020-2034 (USD Billion)
    • 9.4.8.3. Italy: Formulation Development Outsourcing Market, by End Use, 2020-2034 (USD Billion)
    • 9.4.8.4. Italy: Formulation Development Outsourcing Market, by Therapeutic Area, 2020-2034 (USD Billion)
  • 9.4.9. Formulation Development Outsourcing Market - Spain
    • 9.4.9.1. Spain: Formulation Development Outsourcing Market, By Formulation, 2020-2034 (USD Billion)
    • 9.4.9.2. Spain: Formulation Development Outsourcing Market, By Service, 2020-2034 (USD Billion)
    • 9.4.9.3. Spain: Formulation Development Outsourcing Market, by End Use, 2020-2034 (USD Billion)
    • 9.4.9.4. Spain: Formulation Development Outsourcing Market, by Therapeutic Area, 2020-2034 (USD Billion)
  • 9.4.10. Formulation Development Outsourcing Market - Netherlands
    • 9.4.10.1. Netherlands: Formulation Development Outsourcing Market, By Formulation, 2020-2034 (USD Billion)
    • 9.4.10.2. Netherlands: Formulation Development Outsourcing Market, By Service, 2020-2034 (USD Billion)
    • 9.4.10.3. Netherlands: Formulation Development Outsourcing Market, by End Use, 2020-2034 (USD Billion)
    • 9.4.10.4. Netherlands: Formulation Development Outsourcing Market, by Therapeutic Area, 2020-2034 (USD Billion)
  • 9.4.11. Formulation Development Outsourcing Market - Russia
    • 9.4.11.1. Russia: Formulation Development Outsourcing Market, By Formulation, 2020-2034 (USD Billion)
    • 9.4.11.2. Russia: Formulation Development Outsourcing Market, By Service, 2020-2034 (USD Billion)
    • 9.4.11.3. Russia: Formulation Development Outsourcing Market, by End Use, 2020-2034 (USD Billion)
    • 9.4.11.4. Russia: Formulation Development Outsourcing Market, by Therapeutic Area, 2020-2034 (USD Billion)
  • 9.4.12. Formulation Development Outsourcing Market - Rest of Europe
    • 9.4.12.1. Rest of Europe: Formulation Development Outsourcing Market, By Formulation, 2020-2034 (USD Billion)
    • 9.4.12.2. Rest of Europe: Formulation Development Outsourcing Market, By Service, 2020-2034 (USD Billion)
    • 9.4.12.3. Rest of Europe: Formulation Development Outsourcing Market, by End Use, 2020-2034 (USD Billion)
    • 9.4.12.4. Rest of Europe: Formulation Development Outsourcing Market, by Therapeutic Area, 2020-2034 (USD Billion)
• 9.5. Formulation Development Outsourcing Market - Asia Pacific
  • 9.5.1. Asia Pacific: Formulation Development Outsourcing Market, By Formulation, 2020-2034 (USD Billion)
  • 9.5.2. Asia Pacific: Formulation Development Outsourcing Market, By Service, 2020-2034 (USD Billion)
  • 9.5.3. Asia Pacific: Formulation Development Outsourcing Market, by End Use, 2020-2034 (USD Billion)
  • 9.5.4. Asia Pacific: Formulation Development Outsourcing Market, by Therapeutic Area, 2020-2034 (USD Billion)
  • 9.5.5. Formulation Development Outsourcing Market - China
    • 9.5.5.1. China: Formulation Development Outsourcing Market, By Formulation, 2020-2034 (USD Billion)
    • 9.5.5.2. China: Formulation Development Outsourcing Market, By Service, 2020-2034 (USD Billion)
    • 9.5.5.3. China: Formulation Development Outsourcing Market, by End Use, 2020-2034 (USD Billion)
    • 9.5.5.4. China: Formulation Development Outsourcing Market, by Therapeutic Area, 2020-2034 (USD Billion)
  • 9.5.6. Formulation Development Outsourcing Market - India
    • 9.5.6.1. India: Formulation Development Outsourcing Market, By Formulation, 2020-2034 (USD Billion)
    • 9.5.6.2. India: Formulation Development Outsourcing Market, By Service, 2020-2034 (USD Billion)
    • 9.5.6.3. India: Formulation Development Outsourcing Market, by End Use, 2020-2034 (USD Billion)
    • 9.5.6.4. India: Formulation Development Outsourcing Market, by Therapeutic Area, 2020-2034 (USD Billion)
  • 9.5.7. Formulation Development Outsourcing Market - Malaysia
    • 9.5.7.1. Malaysia: Formulation Development Outsourcing Market, By Formulation, 2020-2034 (USD Billion)
    • 9.5.7.2. Malaysia: Formulation Development Outsourcing Market, By Service, 2020-2034 (USD Billion)
    • 9.5.7.3. Malaysia: Formulation Development Outsourcing Market, by End Use, 2020-2034 (USD Billion)
    • 9.5.7.4. Malaysia: Formulation Development Outsourcing Market, by Therapeutic Area, 2020-2034 (USD Billion)
  • 9.5.8. Formulation Development Outsourcing Market - Japan
    • 9.5.8.1. Japan: Formulation Development Outsourcing Market, By Formulation, 2020-2034 (USD Billion)
    • 9.5.8.2. Japan: Formulation Development Outsourcing Market, By Service, 2020-2034 (USD Billion)
    • 9.5.8.3. Japan: Formulation Development Outsourcing Market, by End Use, 2020-2034 (USD Billion)
    • 9.5.8.4. Japan: Formulation Development Outsourcing Market, by Therapeutic Area, 2020-2034 (USD Billion)
  • 9.5.9. Formulation Development Outsourcing Market - Indonesia
    • 9.5.9.1. Indonesia: Formulation Development Outsourcing Market, By Formulation, 2020-2034 (USD Billion)
    • 9.5.9.2. Indonesia: Formulation Development Outsourcing Market, By Service, 2020-2034 (USD Billion)
    • 9.5.9.3. Indonesia: Formulation Development Outsourcing Market, by End Use, 2020-2034 (USD Billion)
    • 9.5.9.4. Indonesia: Formulation Development Outsourcing Market, by Therapeutic Area, 2020-2034 (USD Billion)
  • 9.5.10. Formulation Development Outsourcing Market - South Korea
    • 9.5.10.1. South Korea: Formulation Development Outsourcing Market, By Formulation, 2020-2034 (USD Billion)
    • 9.5.10.2. South Korea: Formulation Development Outsourcing Market, By Service, 2020-2034 (USD Billion)
    • 9.5.10.3. South Korea: Formulation Development Outsourcing Market, by End Use, 2020-2034 (USD Billion)
    • 9.5.10.4. South Korea: Formulation Development Outsourcing Market, by Therapeutic Area, 2020-2034 (USD Billion)
  • 9.5.11. Formulation Development Outsourcing Market - Australia
    • 9.5.11.1. Australia: Formulation Development Outsourcing Market, By Formulation, 2020-2034 (USD Billion)
    • 9.5.11.2. Australia: Formulation Development Outsourcing Market, By Service, 2020-2034 (USD Billion)
    • 9.5.11.3. Australia: Formulation Development Outsourcing Market, by End Use, 2020-2034 (USD Billion)
    • 9.5.11.4. Australia: Formulation Development Outsourcing Market, by Therapeutic Area, 2020-2034 (USD Billion)
  • 9.5.12. Formulation Development Outsourcing Market - Rest of Asia Pacific
    • 9.5.12.1. Rest of Asia Pacific: Formulation Development Outsourcing Market, By Formulation, 2020-2034 (USD Billion)
    • 9.5.12.2. Rest of Asia Pacific: Formulation Development Outsourcing Market, By Service, 2020-2034 (USD Billion)
    • 9.5.12.3. Rest of Asia Pacific: Formulation Development Outsourcing Market, by End Use, 2020-2034 (USD Billion)
    • 9.5.12.4. Rest of Asia Pacific: Formulation Development Outsourcing Market, by Therapeutic Area, 2020-2034 (USD Billion)
• 9.6. Formulation Development Outsourcing Market - Middle East & Africa
  • 9.6.1. Middle East & Africa: Formulation Development Outsourcing Market, By Formulation, 2020-2034 (USD Billion)
  • 9.6.2. Middle East & Africa: Formulation Development Outsourcing Market, By Service, 2020-2034 (USD Billion)
  • 9.6.3. Middle East & Africa: Formulation Development Outsourcing Market, by End Use, 2020-2034 (USD Billion)
  • 9.6.4. Middle East & Africa: Formulation Development Outsourcing Market, by Therapeutic Area, 2020-2034 (USD Billion)
  • 9.6.5. Formulation Development Outsourcing Market - Saudi Arabia
    • 9.6.5.1. Saudi Arabia: Formulation Development Outsourcing Market, By Formulation, 2020-2034 (USD Billion)
    • 9.6.5.2. Saudi Arabia: Formulation Development Outsourcing Market, By Service, 2020-2034 (USD Billion)
    • 9.6.5.3. Saudi Arabia: Formulation Development Outsourcing Market, by End Use, 2020-2034 (USD Billion)
    • 9.6.5.4. Saudi Arabia: Formulation Development Outsourcing Market, by Therapeutic Area, 2020-2034 (USD Billion)
  • 9.6.6. Formulation Development Outsourcing Market - UAE
    • 9.6.6.1. UAE: Formulation Development Outsourcing Market, By Formulation, 2020-2034 (USD Billion)
    • 9.6.6.2. UAE: Formulation Development Outsourcing Market, By Service, 2020-2034 (USD Billion)
    • 9.6.6.3. UAE: Formulation Development Outsourcing Market, by End Use, 2020-2034 (USD Billion)
    • 9.6.6.4. UAE: Formulation Development Outsourcing Market, by Therapeutic Area, 2020-2034 (USD Billion)
  • 9.6.7. Formulation Development Outsourcing Market - Israel
    • 9.6.7.1. Israel: Formulation Development Outsourcing Market, By Formulation, 2020-2034 (USD Billion)
    • 9.6.7.2. Israel: Formulation Development Outsourcing Market, By Service, 2020-2034 (USD Billion)
    • 9.6.7.3. Israel: Formulation Development Outsourcing Market, by End Use, 2020-2034 (USD Billion)
    • 9.6.7.4. Israel: Formulation Development Outsourcing Market, by Therapeutic Area, 2020-2034 (USD Billion)
  • 9.6.8. Formulation Development Outsourcing Market - South Africa
    • 9.6.8.1. South Africa: Formulation Development Outsourcing Market, By Formulation, 2020-2034 (USD Billion)
    • 9.6.8.2. South Africa: Formulation Development Outsourcing Market, By Service, 2020-2034 (USD Billion)
    • 9.6.8.3. South Africa: Formulation Development Outsourcing Market, by End Use, 2020-2034 (USD Billion)
    • 9.6.8.4. South Africa: Formulation Development Outsourcing Market, by Therapeutic Area, 2020-2034 (USD Billion)
  • 9.6.9. Formulation Development Outsourcing Market - Rest of Middle East & Africa
    • 9.6.9.1. Rest of Middle East & Africa: Formulation Development Outsourcing Market, By Formulation, 2020-2034 (USD Billion)
    • 9.6.9.2. Rest of Middle East & Africa: Formulation Development Outsourcing Market, By Service, 2020-2034 (USD Billion)
    • 9.6.9.3. Rest of Middle East & Africa: Formulation Development Outsourcing Market, by End Use, 2020-2034 (USD Billion)
    • 9.6.9.4. Rest of Middle East & Africa: Formulation Development Outsourcing Market, by Therapeutic Area, 2020-2034 (USD Billion)
• 9.7. Formulation Development Outsourcing Market - Latin America
  • 9.7.1. Latin America: Formulation Development Outsourcing Market, By Formulation, 2020-2034 (USD Billion)
  • 9.7.2. Latin America: Formulation Development Outsourcing Market, By Service, 2020-2034 (USD Billion)
  • 9.7.3. Latin America: Formulation Development Outsourcing Market, by End Use, 2020-2034 (USD Billion)
  • 9.7.4. Latin America: Formulation Development Outsourcing Market, by Therapeutic Area, 2020-2034 (USD Billion)
  • 9.7.5. Formulation Development Outsourcing Market - Mexico
    • 9.7.5.1. Mexico: Formulation Development Outsourcing Market, By Formulation, 2020-2034 (USD Billion)
    • 9.7.5.2. Mexico: Formulation Development Outsourcing Market, By Service, 2020-2034 (USD Billion)
    • 9.7.5.3. Mexico: Formulation Development Outsourcing Market, by End Use, 2020-2034 (USD Billion)
    • 9.7.5.4. Mexico: Formulation Development Outsourcing Market, by Therapeutic Area, 2020-2034 (USD Billion)
  • 9.7.6. Formulation Development Outsourcing Market - Brazil
    • 9.7.6.1. Brazil: Formulation Development Outsourcing Market, By Formulation, 2020-2034 (USD Billion)
    • 9.7.6.2. Brazil: Formulation Development Outsourcing Market, By Service, 2020-2034 (USD Billion)
    • 9.7.6.3. Brazil: Formulation Development Outsourcing Market, by End Use, 2020-2034 (USD Billion)
    • 9.7.6.4. Brazil: Formulation Development Outsourcing Market, by Therapeutic Area, 2020-2034 (USD Billion)
  • 9.7.7. Formulation Development Outsourcing Market - Argentina
    • 9.7.7.1. Argentina: Formulation Development Outsourcing Market, By Formulation, 2020-2034 (USD Billion)
    • 9.7.7.2. Argentina: Formulation Development Outsourcing Market, By Service, 2020-2034 (USD Billion)
    • 9.7.7.3. Argentina: Formulation Development Outsourcing Market, by End Use, 2020-2034 (USD Billion)
    • 9.7.7.4. Argentina: Formulation Development Outsourcing Market, by Therapeutic Area, 2020-2034 (USD Billion)
  • 9.7.8. Formulation Development Outsourcing Market - Rest of Latin America
    • 9.7.8.1. Rest of Latin America: Formulation Development Outsourcing Market, By Formulation, 2020-2034 (USD Billion)
    • 9.7.8.2. Rest of Latin America: Formulation Development Outsourcing Market, By Service, 2020-2034 (USD Billion)
    • 9.7.8.3. Rest of Latin America: Formulation Development Outsourcing Market, by End Use, 2020-2034 (USD Billion)
    • 9.7.8.4. Rest of Latin America: Formulation Development Outsourcing Market, by Therapeutic Area, 2020-2034 (USD Billion)

10. Competitive Landscape

• 10.1. Expansion and Acquisition Analysis
  • 10.1.1. Expansion
  • 10.1.2. Acquisitions
• 10.2. Partnerships/Collaborations/Agreements/Exhibitions

11. Company Profiles

• 11.1. Catalent Inc.
  • 11.1.1. Company Overview
  • 11.1.2. Financial Performance
  • 11.1.3. Product Benchmarking
  • 11.1.4. Recent Development
• 11.2. Charles River Laboratories International, Inc.
  • 11.2.1. Company Overview
  • 11.2.2. Financial Performance
  • 11.2.3. Product Benchmarking
  • 11.2.4. Recent Development
• 11.3. Element
  • 11.3.1. Company Overview
  • 11.3.2. Financial Performance
  • 11.3.3. Product Benchmarking
  • 11.3.4. Recent Development
• 11.4. Eurofins Scientific SE
  • 11.4.1. Company Overview
  • 11.4.2. Financial Performance
  • 11.4.3. Product Benchmarking
  • 11.4.4. Recent Development
• 11.5. Intertek Group plc
  • 11.5.1. Company Overview
  • 11.5.2. Financial Performance
  • 11.5.3. Product Benchmarking
  • 11.5.4. Recent Development
• 11.6. Labcorp
  • 11.6.1. Company Overview
  • 11.6.2. Financial Performance
  • 11.6.3. Product Benchmarking
  • 11.6.4. Recent Development
• 11.7. Lonza
  • 11.7.1. Company Overview
  • 11.7.2. Financial Performance
  • 11.7.3. Product Benchmarking
  • 11.7.4. Recent Development
• 11.8. Recipharm
  • 11.8.1. Company Overview
  • 11.8.2. Financial Performance
  • 11.8.3. Product Benchmarking
  • 11.8.4. Recent Development
• 11.9. SGS S.A.
  • 11.9.1. Company Overview
  • 11.9.2. Financial Performance
  • 11.9.3. Product Benchmarking
  • 11.9.4. Recent Development
• 11.10. Thermo Fisher Scientific, Inc.
  • 11.10.1. Company Overview
  • 11.10.2. Financial Performance
  • 11.10.3. Product Benchmarking
  • 11.10.4. Recent Development